Sumadan
Pricing Report NDC 43538-191-16

Latest NADAC: $803.84862 per EA · Effective Jul 31, 2020 · Est. package price $803.85 (1 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Sumadan (NDC 43538-191-16) is $803.84862 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 31, 2020.

As a provided by Medimetriks Pharmaceuticals Inc., this medication is distributed in a 1 KIT in 1 CARTON * 1 BOTTLE, PUMP in 1 CARTON / 454 g in 1 BOTTLE, PUMP * 1 BOTTLE, PUMP in 1 CARTON / 454 g in 1 BOTTLE, PUMP configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$803.84862
Per EA

Effective Date
Jul 31, 2020
Billable Units
1 EA
Estimated Package Price
$803.85
Data Status
As of Jul 14, 2021
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 KIT in 1 CARTON * 1 BOTTLE, PUMP in 1 CARTON / 454 g in 1 BOTTLE, PUMP * 1 BOTTLE, PUMP in 1 CARTON / 454 g in 1 BOTTLE, PUMP
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2013, the NADAC wholesale price for (NDC ) has moved within a range of $286.15191 to $803.84862 per EA. Over this 6 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$286.1519 - $803.8486
Market Volatility
180.92% Variance
Latest Trend
5.57%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 31, 2020 $803.84862 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Jul 31, 2020 $803.84862 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Sep 19, 2019 $761.40054 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Sep 19, 2019 $761.40054 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Jun 28, 2019 $698.52619 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Jun 28, 2019 $698.52619 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 01, 2019 $662.32987 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Mar 01, 2019 $662.32987 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Aug 31, 2018 $633.39026 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Aug 31, 2018 $633.39026 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Dec 29, 2017 $616.43821 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Dec 29, 2017 $616.43821 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026